Fri 1/18/2019 23:29 ET
DJIA24706.35340.951.38%TELCO167.161.290.77%GOLD1281.1511.150.87%Shanghai2579.7620.380.79%
S&P 5002670.7135.251.32%BANKS435.736.971.60%OIL53.731.663.09%BITCOIN3665.8217.960.49%
NASDAQ7157.2373.721.03%PHARM556.302.670.48%US/EU1.140.000.00%Futures2677.3842.031.57%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Immunomedics - IMMU)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  
From: singhtelecom (Rep: 959) reply to singhtelecomDate: 05/16/2018 22:16
Forum: Wall Street Pit - Msg #2734395 - List IMMU msgs Thread #674006374 (Rec: 0)
HE KNEW this great news Re: 1,600 June 20 calls bought from 1.30-1.35 above open interest of 212 contract...

reports 'positive' data for sacituzumab govitecan, its metastatic breast cancer drug (19.51 +0.73)
Co announces that sacituzumab govitecan, its lead investigational ADC, induced promising objective responses as a single agent in heavily pre-treated patients with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Sacituzumab govitecan treatment was generally well tolerated, with no treatment-related deaths. Consistent with safety data obtained in metastatic TNBC, grade 3 or 4 toxicity with greater than 10 percent frequency included neutropenia and leukopenia. There was one case of grade 3/4 diarrhea and febrile neutropenia.



Reply to singhtelecom - Msg #941 - 05/01/2018 10:25


1,600 June 20 calls bought from 1.30-1.35 above open interest of 212 contracts. Stock 18.21. EPS *estimated* 5/9 after close.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreIMMU: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.